Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

784.20 +17.60 (+2.30%)
Streaming Delayed Price Updated: 12:42 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,031,704
Open 761.95
Bid (Size) 783.96 (1)
Ask (Size) 784.30 (1)
Prev. Close 766.60
Today's Range 760.49 - 789.29
52wk Range 624.68 - 972.53
Shares Outstanding N/A
Dividend Yield 0.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
Novo Nordisk may have found a winner in amycretin. 
Via The Motley Fool
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk
While the other companies are testing weight-loss drugs, Allurion has a different approach to obesity. 
Via Investor's Business Daily

Performance

YTD
+0.79%
+0.79%
1 Month
-1.44%
-1.44%
3 Month
-12.02%
-12.02%
6 Month
-4.50%
-4.50%
1 Year
+23.75%
+23.75%

More News

Read More
3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
Via The Motley Fool
Novo Nordisk Stock Eyes Best Day In 17 Months On New Obesity Drug Trial Data: Retail Breathes Easy
Via Stocktwits
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
Via Investor's Business Daily
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
Via The Motley Fool
Is Novo Nordisk Stock a Buy?
Via The Motley Fool
How Is The Market Feeling About Eli Lilly?
Via Benzinga
Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?
Via The Motley Fool
Topics Earnings
Exposures Financial
My Top 5 Stocks to Buy in Early 2025
Via The Motley Fool
5 Stocks On Sale: Values Or Traps?
Via Talk Markets
Topics Stocks / Equities
Maxwell Biosciences Announces Appointment of José Antonio Alas to Its Board of Directors
Via Newsfile
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
Via MarketBeat
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Via Benzinga
Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound
Via Benzinga
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
Should You Buy the Dip in Eli Lilly Stock Right Now?
Via The Motley Fool
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
Via The Motley Fool
3 Unstoppable Stocks to Buy in 2025
Via The Motley Fool
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
Via The Motley Fool
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Via Benzinga
Topics Government
Exposures Political
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Novo Nordisk Stock Tumbles As Ozempic Faces US Pricing Scrutiny, Semaglutide Trial Underwhelms: Retail Gets Anxious
Via Stocktwits
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.